Telo Genomics Corp. (TELO:TSXV) closed at $0.045 on November 4, 2026, unchanged on the day. The stock trades 57.1% below its 52-week high of $0.105 and 80.0% above its 52-week low of $0.025. Over the past year, it lost 40.0%. Telo Genomics Corp. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, TELO closed higher on 38 days (15%). Its best day was September 30, 2026 (+42.86%) and its worst was October 21, 2026 (-21.43%). The stock moved 10% or more in a single session 55 times. It opened at least 5% above the previous day's high 23 times.
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.
Find more stocks like TELO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.